TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Life Science Byrån LSB AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,450
|
1,507
|
1,495 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
431
|
548
|
606 |
| EBITDA |
421
|
548
|
606 |
| Total assets |
1,448
|
1,420
|
1,238 |
| Current assets |
1,148
|
1,240
|
1,178 |
| Current liabilities |
204
|
216
|
189 |
| Equity capital |
1,173
|
1,133
|
978 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
81.0%
|
79.8%
|
79.0% |
| Turnover per employee |
1,450
|
1,507
|
1,495 |
| Profit as a percentage of turnover |
29.7%
|
36.4%
|
40.5% |
| Return on assets (ROA) |
29.8%
|
38.6%
|
48.9% |
| Current ratio |
562.7%
|
574.1%
|
623.3% |
| Return on equity (ROE) |
36.7%
|
48.4%
|
62.0% |
| Change turnover |
-57
|
12
|
117 |
| Change turnover % |
-4%
|
1%
|
8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.